Evolution of treatment for nasopharyngeal cancer--success and setback in the intensity-modulated radiotherapy era.
about
A Review: Proteomics in Nasopharyngeal CarcinomaWhat Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis.Long-term Patterns of Regional Failure for Nasopharyngeal Carcinoma following Intensity-Modulated Radiation Therapy.Effect of Prolonged Radiotherapy Treatment Time on Survival Outcomes after Intensity-Modulated Radiation Therapy in Nasopharyngeal CarcinomaPropensity-matched analysis of three different chemotherapy sequences in patients with locoregionally advanced nasopharyngeal carcinoma treated using intensity-modulated radiotherapy.Multimodality Treatment May Improve the Survival Rate of Patients with Metastatic Nasopharyngeal Carcinoma with Good Performance Status.Tumor Regression and Patterns of Distant Metastasis of T1-T2 Nasopharyngeal Carcinoma with Intensity-Modulated Radiotherapy.Efficacy of Concurrent Chemotherapy for Intermediate Risk NPC in the Intensity-Modulated Radiotherapy Era: a Propensity-Matched Analysis.Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.Prognostic Value of Plasma Epstein-Barr Virus DNA for Local and Regionally Advanced Nasopharyngeal Carcinoma Treated With Cisplatin-Based Concurrent Chemoradiotherapy in Intensity-Modulated Radiotherapy Era.Clinical Outcome and Prognostic Factors of Intensity-Modulated Radiotherapy for T4 Stage Nasopharyngeal Carcinoma.HOPX hypermethylation promotes metastasis via activating SNAIL transcription in nasopharyngeal carcinoma.T4/N2 classification nasopharyngeal carcinoma benefit from concurrent chemotherapy in the era of intensity-modulated radiotherapy.Investigation of long-term survival outcomes and failure patterns of patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: a retrospective analysis.Decreased expression of the NKG2D ligand ULBP4 may be an indicator of poor prognosis in patients with nasopharyngeal carcinoma.IMRT vs. 2D-radiotherapy or 3D-conformal radiotherapy of nasopharyngeal carcinoma : Survival outcome in a Korean multi-institutional retrospective study (KROG 11-06).Chemotherapy for Nasopharyngeal Cancer: Neoadjuvant, Concomitant, and/or Adjuvant.Outcome of nasopharyngeal carcinoma in Finland: A nationwide study.AHNS Series - Do you know your guidelines? Principles of treatment for nasopharyngeal cancer: A review of the National Comprehensive Cancer Network guidelines.Induction chemotherapy followed by intensity-modulated radiotherapy with reduced gross tumor volume delineation for stage T3-4 nasopharyngeal carcinomaUse of transoral nasopharyngeal brush biopsy for Epstein-Barr virus DNA detection of local recurrence of nasopharyngeal carcinoma after radiotherapy.The feasibility analysis of omission of elective irradiation to level IB lymph nodes in low-risk nasopharyngeal carcinoma based on the 2013 updated consensus guideline for neck nodal levels.Nasopharyngeal carcinoma with intracranial extension in the era of intensity-modulated radiotherapy: case-control study using propensity score matching method.Who benefited most from higher cumulative dose of cisplatin among patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiation therapy? A retrospective study of 527 cases.Cetuximab and Cisplatin Show Different Combination Effect in Nasopharyngeal Carcinoma Cells Lines via Inactivation of EGFR/AKT Signaling Pathway.An evaluation of nutrition intervention during radiation therapy in patients with locoregionally advanced nasopharyngeal carcinoma.A comparison of weekly versus 3-weekly cisplatin during concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma using intensity modulated radiation therapy: a matched study.Association between XRCC1 single-nucleotide polymorphism and acute radiation reaction in patients with nasopharyngeal carcinoma: A cohort study.Efficacy and Safety of Chemotherapy Combined with Stereotactic Radiotherapy in the Treatment of Nasopharyngeal Carcinoma.SEOM clinical guideline in nasopharynx cancer (2017).Comparison of intensity modulated radiotherapy with simultaneous integrated boost (IMRT-SIB) and a 3-dimensional conformal parotid gland-sparing radiotherapy (ConPas 3D-CRT) in treatment of nasopharyngeal carcinoma: a mono-institutional experience.Tumor response to neoadjuvant chemotherapy predicts long-term survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: A secondary analysis of a randomized phase 3 clinical trial.The value of the Prognostic Nutritional Index (PNI) in predicting outcomes and guiding the treatment strategy of nasopharyngeal carcinoma (NPC) patients receiving intensity-modulated radiotherapy (IMRT) with or without chemotherapy.Reduced QSOX1 enhances radioresistance in nasopharyngeal carcinoma.Magnetic Resonance Imaging-Detected Intracranial Extension in the T4 Classification Nasopharyngeal Carcinoma with Intensity-Modulated Radiotherapy.Evolution of postirradiated sudden deafness in nasopharyngeal carcinoma survivors during the past two decades.Patterns of Failure and Survival Trends Of 720 Patients with Stage I Nasopharyngeal Carcinoma Diagnosed from 1990-2012: A Large-scale Retrospective Cohort Study.Impact of minimum point dose on local control and toxicity in T3-4 nasopharyngeal carcinoma treated with intensity-modulated radiation therapy plus chemotherapy.Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma.[The best multimodal treatment for locally advanced nasopharyngeal carcinoma : An update of the MAC-NPC data].
P2860
Q26800017-6B8FEA54-8B79-4F87-A8A0-B41CAAFED1D4Q31146986-579DA7BB-4B52-40AC-B4A5-CFBCAFB8C161Q33702326-715AC621-A0E8-405A-B960-9DB3A6747010Q35823230-8BDD1A1F-0700-42CA-9ED8-44C0EE1AE0F0Q35823316-A73005B7-162A-4FFA-B2D9-6A5252D93B94Q35891717-672D5C64-2984-45B9-8410-86FF8A62E30DQ36000811-0011849D-5048-48FA-9A04-F08F8E4A8AB2Q36324291-8035AD28-7EE7-4E30-B555-936C4E94073AQ36546073-18D9260E-1609-4F5A-A863-333117EA3703Q36566873-D6991C48-2574-479A-8A86-DCC57732255FQ36860991-70A66231-917E-4704-A459-74C63BC3A3FDQ37630359-2D085D30-6B45-4AB5-BE66-633A8333D280Q37697250-A0C70C7A-288E-4AB3-8BBB-445D9A3042BCQ37699348-40AB110E-CE5D-4EEA-91B6-D6A31B9CAA10Q38376092-9E43A6D7-F0F6-4910-882E-026B2F92E229Q38416252-51A222F8-B466-48D4-9A6B-D9AF5FEB7998Q38549748-DA38AA1C-696F-4EED-89EA-3340F5E00A3BQ38689454-56C31BA5-D46B-43C9-B7DC-3E29EE6C5DE3Q39023470-C325CDF9-CC0C-4005-BE32-10EF964DF24CQ40983645-0444F59B-8C16-43F7-B520-1246F9EB06BAQ41333975-64333F96-5181-4F7F-B58E-A2E54208931FQ41451059-7B3F793A-899F-417F-86F1-6EC8D8144C72Q41475008-DD291805-D0A5-44BE-8396-0F6A30E40219Q41721746-D218EF50-7949-4F5E-B569-48E40687766FQ41852684-06688BFA-9F19-42DE-8988-C31791D0653DQ46888087-E3B39B91-7F69-4361-B0D8-AA40DCAB8C38Q47115446-42EF62A0-B282-4FA2-9487-55C80A0D1AE6Q47129161-C0B8E6C0-58D3-4A8D-A6D2-CAB5BC582C05Q47148858-C49DBA04-41AB-443D-B246-B5B78A4358F7Q48370700-AFD7836F-1715-4FB1-8B3A-628E3D21A6FAQ48378684-1ABC55EB-DDC5-424F-A1CE-2B3F40EF970FQ48720212-D6E827C9-1E97-4F8D-892A-6F32CD14386AQ48819215-D808BDAA-5702-4B08-BCF4-522C98A435E3Q50105730-342075E2-324F-4A0A-913F-EA9A3E704D2FQ50114649-7D5A8D34-C3ED-4DEA-B67A-8C6B0A56C25EQ50317100-CD25AB56-B68F-4B8F-9C3C-A09AE92D7DA1Q52576030-9EBA6D6E-FF29-44CE-91B3-416AC9D62D9EQ52732435-51673AF0-F839-4A96-B03F-5CB2F0E30142Q52952632-F0924EA5-BD6B-4C1A-B0A4-C4067DFB3897Q54059101-72D55CD7-D703-4134-AB39-5F06701BD75E
P2860
Evolution of treatment for nasopharyngeal cancer--success and setback in the intensity-modulated radiotherapy era.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Evolution of treatment for nas ...... ty-modulated radiotherapy era.
@en
type
label
Evolution of treatment for nas ...... ty-modulated radiotherapy era.
@en
prefLabel
Evolution of treatment for nas ...... ty-modulated radiotherapy era.
@en
P2093
P1476
Evolution of treatment for nas ...... ty-modulated radiotherapy era.
@en
P2093
Amy T Y Chang
Anne W M Lee
Connie C C Chan
Henry C K Sze
Lucy L K Chan
Oscar S H Chan
Rebecca M W Yeung
Wai Man Hung
P304
P356
10.1016/J.RADONC.2014.02.003
P50
P577
2014-03-11T00:00:00Z